| Product Code: ETC7642684 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland continued to rely on key countries for vaccine contract manufacturing imports, with the USA, UK, Germany, Metropolitan France, and Serbia leading the way. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI), the market experienced a decline with a negative Compound Annual Growth Rate (CAGR) of -4.18% from 2020 to 2024. The growth rate in 2024 saw a significant drop of -30.16%, reflecting challenges faced by the industry. This data indicates the importance of monitoring trends and adapting strategies to navigate the evolving landscape of vaccine manufacturing imports in Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Vaccine Contract Manufacturing Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Vaccine Contract Manufacturing Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Vaccine Contract Manufacturing Market - Industry Life Cycle |
3.4 Ireland Vaccine Contract Manufacturing Market - Porter's Five Forces |
3.5 Ireland Vaccine Contract Manufacturing Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Ireland Vaccine Contract Manufacturing Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Ireland Vaccine Contract Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for vaccines globally |
4.2.2 Government initiatives to promote vaccine manufacturing in Ireland |
4.2.3 Rise in outsourcing of vaccine production by pharmaceutical companies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for vaccine manufacturing |
4.3.2 High initial investment and operational costs |
4.3.3 Limited availability of skilled workforce in the vaccine manufacturing sector |
5 Ireland Vaccine Contract Manufacturing Market Trends |
6 Ireland Vaccine Contract Manufacturing Market, By Types |
6.1 Ireland Vaccine Contract Manufacturing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Vaccine Contract Manufacturing Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Ireland Vaccine Contract Manufacturing Market Revenues & Volume, By Fill-Finish, 2022 - 2032F |
6.1.4 Ireland Vaccine Contract Manufacturing Market Revenues & Volume, By Bulk Product, 2022 - 2032F |
6.2 Ireland Vaccine Contract Manufacturing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Vaccine Contract Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.2.3 Ireland Vaccine Contract Manufacturing Market Revenues & Volume, By Biotech Companies, 2022 - 2032F |
6.2.4 Ireland Vaccine Contract Manufacturing Market Revenues & Volume, By Others, 2022 - 2032F |
7 Ireland Vaccine Contract Manufacturing Market Import-Export Trade Statistics |
7.1 Ireland Vaccine Contract Manufacturing Market Export to Major Countries |
7.2 Ireland Vaccine Contract Manufacturing Market Imports from Major Countries |
8 Ireland Vaccine Contract Manufacturing Market Key Performance Indicators |
8.1 Percentage increase in research and development investments by pharmaceutical companies in Ireland |
8.2 Number of new vaccine manufacturing facilities established in Ireland |
8.3 Growth in partnerships and collaborations between Irish contract manufacturers and global pharmaceutical companies |
9 Ireland Vaccine Contract Manufacturing Market - Opportunity Assessment |
9.1 Ireland Vaccine Contract Manufacturing Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Ireland Vaccine Contract Manufacturing Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Ireland Vaccine Contract Manufacturing Market - Competitive Landscape |
10.1 Ireland Vaccine Contract Manufacturing Market Revenue Share, By Companies, 2025 |
10.2 Ireland Vaccine Contract Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here